3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Solid Tumor
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Glioma
1
Glioblastoma
1
Colorectal Neoplasms
1
Colorectal Cancer Metastatic
1
Interventions
Capecitabine
6
Bevacizumab
5
trifluridine tipiracil drug combination
3
Cetuximab
3
Oxaliplatin
2
sintilimab
1
monoclonal antibody YYB-101
1
aflibercept
1
Vemurafenib
1
Nivolumab
1
LY-2157299
1
Irinotecan
1
HMPL-013
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Colorectal Cancer Metastatic
×
LY-2157299
×
Clear all
NCT03470350
2019-07-24
EORTC1615
The Netherlands Cancer Institute
Phase 1/2
Withdrawn